RECURRENT ACUTE MYELOID LEUKEMIA
Clinical trials for RECURRENT ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for tough blood cancers in older adults
Disease control TerminatedThis study tested how well two chemotherapy drugs, venetoclax and decitabine, work together to control aggressive blood cancers. It was for older adults newly diagnosed with acute myeloid leukemia (AML) or people whose AML or high-risk myelodysplastic syndrome (MDS) had returned …
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Oral drug combo tested for Tough-to-Treat leukemia relapse
Disease control TerminatedThis study tested whether a combination of three oral medications could help control acute myeloid leukemia (AML) in adults whose cancer returned after a donor stem cell transplant. The goal was to see if the treatment could put the leukemia back into remission and how long patie…
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Sanjay Mohan • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists test new combo against tough blood cancers
Disease control TerminatedThis early-stage study tested a combination of two chemotherapy drugs, pevonedistat and belinostat, in adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that had returned or stopped responding to other treatments. The main goal was to find the highest dos…
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Targeted drug duo tested for tough blood cancers
Disease control TerminatedThis study tested a combination of two drugs, omacetaxine and venetoclax, for adults with acute myeloid leukemia or myelodysplastic syndrome that has returned or stopped responding to treatment, and who have a specific genetic change called RUNX1. The goal was to find the safest,…
Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC